MAPK3 and non-small cell lung carcinoma: Regarding the possible mechanisms involved in ERK1/2-mediated DUSP6 expression in NSCLC, it has been reported that ETS1, a well-known nuclear target of activated ERK1/2, positively modulates DUSP6 expression by binding to its promoter region [132].